Related Experiment Video
Updated: Jun 28, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Smoking-related interstitial lung disease.
R Nagarjun Rao1, Lawrence R Goodman, Joseph F Tomashefski
1Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. arao@mcw.edu
Annals of Diagnostic Pathology
|November 11, 2008
Summary
Smoking is linked to interstitial lung diseases (ILDs), including respiratory bronchiolitis, desquamative interstitial pneumonia, and pulmonary Langerhans cell histiocytosis. These smoking-related ILDs may represent a spectrum, with biopsy crucial for diagnosis and management.
Area of Science:
- Pulmonology
- Pathology
- Epidemiology
Background:
- Tobacco smoking is a major cause of pulmonary diseases, including COPD and lung cancer.
- Interstitial lung diseases (ILDs) are increasingly recognized as being associated with smoking.
- Specific smoking-related ILDs include respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, and pulmonary Langerhans cell histiocytosis.
Purpose of the Study:
- To explore the link between smoking and specific interstitial lung diseases.
- To investigate the clinical, radiologic, and pathologic similarities among smoking-related ILDs.
- To highlight the importance of distinguishing these entities for appropriate clinical management.
Main Methods:
- Review of epidemiologic evidence establishing the relationship between smoking and ILDs.
- Analysis of clinical, radiologic, and pathologic features of respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, and pulmonary Langerhans cell histiocytosis.
- Emphasis on the role of surgical lung biopsy in differentiating these conditions.
Main Results:
- Smoking is strongly associated with respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, and pulmonary Langerhans cell histiocytosis.
- These three conditions share significant clinical, radiologic, and pathologic features.
- Distinguishing between these entities can be challenging, even with histologic evaluation.
Conclusions:
- Smoking-related interstitial lung diseases may represent a spectrum of disease in susceptible individuals.
- Accurate diagnosis through histologic evaluation is critical due to differing management strategies.
- Further research, including genetic factors, is needed to fully understand these conditions.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.